NSE : ADVENZYMES.NS
-$5.75 (-1.82%)
NSE
Beni Prasad Rauka
Chemicals - Specialty
Basic Materials
ADVENZYMES.NS
409
IN
INR
0.02
9.78
8.12
1.09
0.35
$7.46B
4.67
2.13
75.06
4.14
$15.06
$1.69B
22.62%
31.18%
11.03%
9.18%
20.61
0.72
0.72
4/5
0 Analysts
%
15.15
8/9
$9.37B
$18.39B
$1.56B
$2.35B
No key metrics data available.
| Name | Title |
|---|---|
| Michael Puls | MD & Head of Research and Development - evoxx technologies GmbH |
| Harshad Doshi | Chief Financial Officer & Chief Operating Officer of US Subsidiaries |
| Ronak Saraf | Investor Relations Manager |
| Martina Doering | MD & Head of Business Development - evoxx technologies GmbH |
| Satish Pagar | Plant Manager & Head of Operations - Sinnar |
| Sanjay Prakash Basantani | Company Secretary, Head of Legal & Compliance Officer |
| Beni Prasad Rauka | Chief Financial Officer |
| Bhaskar Manolkar | General Manager of Human Resources & Administration |
No votes yet today — be the first to share your view!
About Advanced Enzyme Technologies Limited (NSE:ADVENZYMES.NS) Stock
Advanced Enzyme Technologies Limited, headquartered in Thane, India, is a global company engaged in the research, development, manufacturing, and marketing of enzymes and probiotics. Its operations span India, the United States, Asia, and Europe. The company's diverse enzyme offerings cater to human healthcare, animal nutrition, and an extensive range of food processing sectors, including fruit and vegetable, baking, brewing, malting, grain, protein modification, yeast, dairy, and oils/fats processing, as well as various specialty applications. Beyond food-related uses, it also supplies industrial enzymes for non-food industries like textile processing, leather, pulp and paper production, detergents and cleaning aids, biofuels, and biocatalysis. Founded in 1957, the company was previously ... known as Advanced Biochemicals Limited before changing its name to Advanced Enzyme Technologies Limited in 2005.
Frequently Asked Questions
What is the current Advanced Enzyme Technologies Limited (ADVENZYMES.NS) stock price?
Advanced Enzyme Technologies Limited(NSE:ADVENZYMES.NS) stock price is $310.85 in the last trading session. During the trading session, ADVENZYMES.NS stock reached the peak price of $419 while $251.95 was the lowest point it dropped to. The percentage change in ADVENZYMES.NS stock occurred in the recent session was --1.82% while the dollar amount for the price change in ADVENZYMES.NS stock was -$5.75.
ADVENZYMES.NS's industry and sector of operation?
The NSE listed ADVENZYMES.NS is part of Chemicals - Specialty industry that operates in the broader Basic Materials sector.
Who are the executives of ADVENZYMES.NS?
Michael Puls
| MD & Head of Research and Development - evoxx technologies GmbH
Harshad Doshi
| Chief Financial Officer & Chief Operating Officer of US Subsidiaries
Ronak Saraf
| Investor Relations Manager
Martina Doering
| MD & Head of Business Development - evoxx technologies GmbH
Satish Pagar
| Plant Manager & Head of Operations - Sinnar
How many employees does ADVENZYMES.NS have?
Number of ADVENZYMES.NS employees currently stands at 409. ADVENZYMES.NS operates from Sun Magnetica, Thane, MA 400604, IN.
Link for ADVENZYMES.NS official website?
Official Website of ADVENZYMES.NS is: https://www.advancedenzymes.com
How do I contact ADVENZYMES.NS?
ADVENZYMES.NS could be contacted at phone #91 22 4170 3200 and can also be accessed through its website. ADVENZYMES.NS operates from Sun Magnetica, Thane, MA 400604, IN.
How many shares of ADVENZYMES.NS are traded daily?
The average number of ADVENZYMES.NS shares traded daily for last 3 months was 446.87K.
What is the market cap of ADVENZYMES.NS currently?
The market value of ADVENZYMES.NS currently stands at $34.81B with its latest stock price at $310.85